Literature DB >> 30789668

Choosing a Time Horizon in Cost and Cost-effectiveness Analyses.

Anirban Basu1, Matthew L Maciejewski2,3.   

Abstract

Mesh：

Year:  2019        PMID： 30789668     DOI： 10.1001/jama.2019.1153

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.

Authors:  Sónia Romano; Débora Figueira; Inês Teixeira; Julian Perelman
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981

2.  RACE-IT - Rapid Acute Coronary Syndrome Exclusion using the Beckman Coulter Access high-sensitivity cardiac troponin I: A stepped-wedge cluster randomized trial.

Authors:  Joseph Miller; Bernard Cook; Gulmohar Singh-Kucukarslan; Amy Tang; Shooshan Danagoulian; Gerard Heath; Ziad Khalifa; Phillip Levy; Simon A Mahler; Nicholas Mills; James McCord
Journal:  Contemp Clin Trials Commun       Date:  2021-04-23

3.  Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost-Utility Analysis.

Authors:  John K Peel; Rafael Neves Miranda; David Naimark; Graham Woodward; Mamas A Mamas; Mina Madan; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

4.  Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.

Authors:  Neill Booth; Pekka Rissanen; Teuvo L J Tammela; Paula Kujala; Ulf-Håkan Stenman; Kimmo Taari; Kirsi Talala; Anssi Auvinen
Journal:  PLoS One       Date:  2019-11-05       Impact factor: 3.240

Review 5.  Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions.

Authors:  Fernanda S Tonin; Ignacio Aznar-Lou; Vasco M Pontinha; Roberto Pontarolo; Fernando Fernandez-Llimos
Journal:  Pharm Pract (Granada)       Date:  2021-02-22

6.  Estimated Cost-effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib for Treatment of BRAF V600 Variation Metastatic Melanoma.

Authors:  Chao Cai; Ismaeel Yunusa; Ahmad Tarhini
Journal:  JAMA Netw Open       Date:  2021-11-01

7.  Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure.

Authors:  Kotomi Sakai; Ryo Momosaki; Eri Hoshino
Journal:  Cost Eff Resour Alloc       Date:  2022-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.